Maintaining a ‘fit’ immune system: the role of vaccines

References

• Mayr A. Taking advantage of the positive side-effects of smallpox vaccination. J Vet MedInfect Dis Vet Public Health. 2004;51(5):199–201.
   PubMedGoogle Scholar
• Usher NT, Chang S, Howard RS, et al. Association of BCG vaccination in childhood with subsequent cancer diagnoses: a 60-year follow-up of a clinical trial. JAMA network open. 2019;2(9):e1912014.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Soares-Weiser K, Lopez-Lopez JA, et al. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review. BMJ. 2016;355:i5170.
   PubMed Web of Science ®Google Scholar
• Schaltz-Buchholzer F, Kjaer Sorensen M, Benn CS, et al. The introduction of BCG vaccination to neonates in Northern Sweden, 1927–1931: re-analysis of historical data to understand the lower mortality among BCG-vaccinated children. Vaccine. 2022;40(11):1516–1524.
   PubMed Web of Science ®Google Scholar
• Redelman-Sidi G, Glickman MS, Bochner BH. The mechanism of action of BCG therapy for bladder cancer–a current perspective. Nat Rev Urol. 2014;11(3):153–162.
   PubMed Web of Science ®Google Scholar
• Doupis J, Kolokathis K, Markopoulou E, et al. The role of pediatric BCG vaccine in type 1 diabetes onset. Diabetes Ther. 2021;12(11):2971–2976.
   PubMed Web of Science ®Google Scholar
• Corsenac P, Parent ME, Mansaray H, et al. Early life bacillus calmette-guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood. Diabetes Metab. 2022;48(3):101337.
   PubMed Web of Science ®Google Scholar
• Gómez-Rial J, Sánchez-Bátan S, Rivero-Calle I, et al. Rotavirus infection beyond the gut. Infect Drug Resist. 2019;12:55–64.
   PubMed Web of Science ®Google Scholar
• Rogers MAM, Basu T, Kim C. Lower incidence rate of type 1 diabetes after receipt of the rotavirus vaccine in the United States, 2001–2017. Sci Rep. 2019;9(1):7727.
   PubMedGoogle Scholar
• Messina NL, Zimmermann P, Curtis N. The impact of vaccines on heterologous adaptive immunity. Clin Microbiol Infect. 2019;25(12):1484–1493.
   PubMed Web of Science ®Google Scholar
• Netea MG, Dominguez-Andres J, Barreiro LB, et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020;20(6):375–388.
   PubMed Web of Science ®Google Scholar
• Moser M, Leo O. Key concepts in immunology. Vaccine. 2010;28(Suppl 3):C2–13.
   PubMedGoogle Scholar
• Ishii KJ, Koyama S, Nakagawa A, et al. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe. 2008;3(6):352–363.
   PubMed Web of Science ®Google Scholar
• Leo O, Cunningham AL, Stern P. Vaccine immunology. Perspectives Vaccinol. 2011;1(1)25–59.
   Google Scholar
• Imler JL, Hoffmann JA. Toll receptors in innate immunity. Trends Cell Biol. 2001;11(7):304–311.
   PubMed Web of Science ®Google Scholar
• Reinhardt RL, Liang HE, Locksley RM. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat Immunol. 2009;10(4):385–393.
   PubMed Web of Science ®Google Scholar
• Luckheeram RV, Zhou R, Verma AD, et al. CD4⁺T cells: differentiation and functions. Clin Dev Immunol. 2012;925135:2012.
   Google Scholar
• Greene JT, Brian BF, Senevirathne SE, et al. Regulation of myeloid-cell activation. Curr Opin Immunol. 2021;73:34–42
   PubMed Web of Science ®Google Scholar
• Didierlaurent AM, Laupeze B, Di Pasquale A, et al. Adjuvant system AS01: helping to overcome the challenges of modern vaccines. Expert Rev Vaccines. 2017;16(1):55–63.
   PubMed Web of Science ®Google Scholar
• Dominguez-Andres J, Netea MG. Long-term reprogramming of the innate immune system. J Leukoc Biol. 2019;105(2):329–338.
   PubMed Web of Science ®Google Scholar
• Sanchez-Ramon S, Conejero L, Netea MG, et al. Trained immunity-based vaccines: a new paradigm for the development of broad-spectrum anti-infectious formulations. Front Immunol. 2018;9:2936
   PubMed Web of Science ®Google Scholar
• Sohrabi Y, Godfrey R, Findeisen HM. Altered cellular metabolism drives trained immunity. Trends Endocrinol Metab. 2018;29(9):602–605.
   PubMed Web of Science ®Google Scholar
• van der Heijden C, Noz MP, Joosten LAB, et al. Epigenetics and trained immunity. Antioxid Redox Signal. 2018;29(11):1023–1040.
   PubMed Web of Science ®Google Scholar
• Rusek P, Wala M, Druszczynska M, et al. Infectious agents as stimuli of trained innate immunity. Int J Mol Sci. 2018;19(2):465.
   PubMed Web of Science ®Google Scholar
• Mourits VP, Wijkmans JC, Joosten LA, et al. Trained immunity as a novel therapeutic strategy. Curr Opin Pharmacol. 2018;41:52–58
   PubMed Web of Science ®Google Scholar
• Stevens WB, Netea MG, Kater AP et al. ‘Trained immunity’: consequences for lymphoid malignancies. Haematologica. 2016;101(12):1460–1468.
   PubMed Web of Science ®Google Scholar
• van Puffelen JH, Keating ST, Oosterwijk E, et al. Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer. Nat Rev Urol. 2020;17(9):513–525.
   PubMed Web of Science ®Google Scholar
• Ter Steeg L, Dominguez-Andres J, Netea MG, et al. Trained immunity as a preventive measure for surgical site infections. Clin Microbiol Rev. 2021;34(4):e0004921.
   PubMed Web of Science ®Google Scholar
• Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin Orthop Relat Res. 1991;105(6):487.
   Google Scholar
• Coley WB. The treatment of inoperable sarcoma by bacterial toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus). Proc R Soc Med. 1910;3(Surg Sect):1–48.
   PubMedGoogle Scholar
• Antonelli AC, Binyamin A, Hohl TM, et al. Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-gamma signaling. Proc Natl Acad Sci U S A. 2020;117(31):18627–18637.
   PubMed Web of Science ®Google Scholar
• Arts RJW, Joosten LAB, Netea MG. The potential role of trained immunity in autoimmune and autoinflammatory disorders. Front Immunol. 2018;9:298
   PubMed Web of Science ®Google Scholar
• Arts RJW, Moorlag S, Novakovic B, et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe. 2018;23(1):89–100 e105.
   PubMed Web of Science ®Google Scholar
• Kaufmann E, Sanz J, Dunn JL, et al. BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell. 2018;172(1–2):176–190 e119.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang H, Chen Z, et al. Proliferation of CD11b+ myeloid cells induced by TLR4 signaling promotes hepatitis B virus clearance. Cytokine. 2022;153:155867
   PubMed Web of Science ®Google Scholar
• Zanoni I, Granucci F. Role of CD14 in host protection against infections and in metabolism regulation. Front Cell Infect Microbiol. 2013;3:32
   PubMed Web of Science ®Google Scholar
• Kleinnijenhuis J, Quintin J, Preijers F, et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A. 2012;109(43):17537–17542.
   PubMed Web of Science ®Google Scholar
• Kleinnijenhuis J, Quintin J, Preijers F, et al. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. J Innate Immun. 2014;6(2):152–158.
   PubMed Web of Science ®Google Scholar
• Kleinnijenhuis J, van Crevel R, Netea MG. Trained immunity: consequences for the heterologous effects of BCG vaccination. Trans R Soc Trop Med Hyg. 2015;109(1):29–35.
   PubMed Web of Science ®Google Scholar
• Keefe RC, Takahashi H, Tran L, et al. BCG therapy is associated with long-term, durable induction of Treg signature genes by epigenetic modulation. Sci Rep. 2021;11(1):14933.
   PubMed Web of Science ®Google Scholar
• Moorlag S, Arts RJW, van Crevel R, et al. Non-specific effects of BCG vaccine on viral infections. Clin Microbiol Infect. 2019;25(12):1473–1478.
   PubMed Web of Science ®Google Scholar
• LAJ O'Neill, Netea MG. BCG-induced trained immunity: can it offer protection against COVID-19? Nat Rev Immunol. 2020;20(6):335–337.
   PubMed Web of Science ®Google Scholar
• Escobar LE, Molina-Cruz A, Barillas-Mury C. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19). Proc Natl Acad Sci U S A. 2020;117(30):17720–17726.
   PubMed Web of Science ®Google Scholar
• Singh S, Maurya RP, Singh RK. Trained immunity” from Mycobacterium spp. exposure or BCG vaccination and COVID-19 outcomes. PLoS Pathog. 2020;16(10):e1008969.
   PubMed Web of Science ®Google Scholar
• Hamiel U, Kozer E, Youngster I. SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults. JAMA. 2020;323(22):2340–2341.
   PubMed Web of Science ®Google Scholar
• Belizario JE. Trained innate immunity, COVID-19 therapeutic dilemma, and fake science. Clinics (Sao Paulo). 2020;75:e2124.
   PubMed Web of Science ®Google Scholar
• Noale M, Trevisan C, Maggi S, et al. The association between influenza and pneumococcal vaccinations and SARS-Cov-2 infection: data from the EPICOVID19 web-based survey. Vaccines (Basel). 2020;8(3):471
   PubMed Web of Science ®Google Scholar
• Debisarun PA, Gossling KL, Bulut O, et al. Induction of trained immunity by influenza vaccination - impact on COVID-19. PLoS Pathog. 2021;17(10):e1009928.
   PubMed Web of Science ®Google Scholar
• Qi Q, Cavanagh MM, Le Saux S, et al. Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination. Sci Transl Med. 2016;8(332):332ra346.
   Web of Science ®Google Scholar
• Bruxvoort KJ, Ackerson B, Sy LS, et al. Recombinant adjuvanted zoster vaccine and reduced risk of COVID-19 diagnosis and hospitalization in older adults. J Infect Dis. 2021;225(11):1915–1922.
   Web of Science ®Google Scholar
• Del Giudice G, Goronzy JJ, Grubeck-Loebenstein B, et al. Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging. NPJ Aging Mech Dis. 2018;4:1.
   PubMed Web of Science ®Google Scholar
• Grolleau-Julius A, Ray D, Yung RL. The role of epigenetics in aging and autoimmunity. Clin Rev Allergy Immunol. 2010;39(1):42–50.
   PubMed Web of Science ®Google Scholar
• Franceschi C, Salvioli S, Garagnani P, et al. Immunobiography and the heterogeneity of immune responses in the elderly: a focus on inflammaging and trained immunity. Front Immunol. 2017;8:982
   PubMed Web of Science ®Google Scholar
• Jasiulionis MG. Abnormal epigenetic regulation of immune system during aging. Front Immunol. 2018;9:197
   PubMed Web of Science ®Google Scholar
• Goronzy JJ, Hu B, Kim C, et al. Epigenetics of T cell aging. J Leukoc Biol. 2018;104(4):691–699.
   PubMed Web of Science ®Google Scholar
• Kananen L, Nevalainen T, Jylhava J, et al. Cytomegalovirus infection accelerates epigenetic aging. Exp Gerontol. 2015;72:227–229
   PubMed Web of Science ®Google Scholar
• Xu M, Zhu J, Liu XD, et al. Roles of physical exercise in neurodegeneration: reversal of epigenetic clock. Transl Neurodegener. 2021;10(1):30.
   PubMed Web of Science ®Google Scholar
• Kresovich JK, Park YM, Keller JA, et al. Healthy eating patterns and epigenetic measures of biological age. Am J Clin Nutr. 2021;115(1):171–179.
   Web of Science ®Google Scholar
• Quach A, Levine ME, Tanaka T, et al. Epigenetic clock analysis of diet, exercise, education, and lifestyle factors. Aging (Albany NY). 2017;9(2):419–446.
   PubMedGoogle Scholar
• Bonanni P. Demographic impact of vaccination: a review. Vaccine. 1999;17(Suppl 3):S120–125.
   PubMed Web of Science ®Google Scholar
• Laupèze B, Del Giudice G, Doherty M, et al. Vaccination as a preventative measure contributing to immune fitness. NPJ Vaccines. 2021;6(1):93.
   PubMed Web of Science ®Google Scholar
• Philip RK, Attwell K, Breuer T, et al. Life-course immunization as a gateway to health. Expert Rev Vaccines. 2018;17(10):851–864.
   PubMed Web of Science ®Google Scholar
• Karin M, Clevers H. Reparative inflammation takes charge of tissue regeneration. Nature. 2016;529(7586):307–315.
   PubMed Web of Science ®Google Scholar
• Caballero-Sanchez N, Alonso-Alonso S, Nagy L. Regenerative inflammation: when immune cells help to re-build tissues. FEBS J. 2022;20:335–337.
   Google Scholar
• Tappenden KA, Deutsch AS. The physiological relevance of the intestinal microbiota–contributions to human health. J Am Coll Nutr. 2007;26(6):679S–683S.
   PubMed Web of Science ®Google Scholar
• Eming SA, Hammerschmidt M, Krieg T, et al. Interrelation of immunity and tissue repair or regeneration. Semin Cell Dev Biol. 2009;20(5):517–527.
   PubMed Web of Science ®Google Scholar
• Liston A, Gray DH. Homeostatic control of regulatory T cell diversity. Nat Rev Immunol. 2014;14(3):154–165.
   PubMed Web of Science ®Google Scholar
• Wang M, Thomson AW, Yu F, et al. T lymphocytes as a therapy for ischemic stroke. Seminars in Immunopathology, 2022. Berlin (Heidelberg): Springer Berlin Heidelberg.
   Google Scholar
• Souquette A, Frere J, Smithey M, et al. A constant companion: immune recognition and response to cytomegalovirus with aging and implications for immune fitness. GeroScience. 2017;39(3):293–303.
   PubMed Web of Science ®Google Scholar
• Lederman MM, Funderburg NT, Sekaly RP, et al. Residual immune dysregulation syndrome in treated HIV infection. Adv Immunol. 2013;119;51–83
   PubMed Web of Science ®Google Scholar
• Mina MJ. Measles, immune suppression and vaccination: direct and indirect nonspecific vaccine benefits. J Infect. 2017;74(Suppl 1):S10–S17.
   PubMedGoogle Scholar
• Mina MJ, Kula T, Leng Y, et al. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science. 2019;366(6465):599–606.
   PubMed Web of Science ®Google Scholar
• Mina MJ, Metcalf CJ, de Swart RL, et al. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science. 2015;348(6235):694–699.
   PubMed Web of Science ®Google Scholar
• Nandi A, Shet A, Behrman JR, et al. Anthropometric, cognitive, and schooling benefits of measles vaccination: longitudinal cohort analysis in Ethiopia, India, and Vietnam. Vaccine. 2019;37(31):4336–4343.
   PubMed Web of Science ®Google Scholar
• Bloom DE, Canning D, Shenoy ES. The effect of vaccination on children’s physical and cognitive development in the Philippines. Appl Econ. 2012;44(21):2777–2783.
   Web of Science ®Google Scholar
• Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis. 2009;9(10):601–610.
   PubMed Web of Science ®Google Scholar
• Nguyen JL, Yang W, Ito K, et al. Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol. 2016;1(3):274–281.
   PubMed Web of Science ®Google Scholar
• Nichol KL. Influenza vaccination in the elderly: impact on hospitalisation and mortality. Drugs Aging. 2005;22(6):495–515.
   PubMed Web of Science ®Google Scholar
• Aidoud A, Marlet J, Angoulvant D, et al. Influenza vaccination as a novel means of preventing coronary heart disease: effectiveness in older adults. Vaccine. 2020;38(32):4944–4955.
   PubMed Web of Science ®Google Scholar
• Saberi A, Akhondzadeh S, Kazemi S, et al. Stroke: a systematic review. Basic Clin Neurosci. 2021;12(4):427–440.
   PubMed Web of Science ®Google Scholar
• Murala S, Nagarajan E, Bollu PC. Infectious causes of stroke. J Stroke Cerebrovasc Dis. 2022;31(4):106274.
   PubMed Web of Science ®Google Scholar
• Amlie-Lefond C, Gilden D. Varicella zoster virus: a common cause of stroke in children and adults. J Stroke Cerebrovasc Dis. 2016;25(7):1561–1569.
   PubMed Web of Science ®Google Scholar
• Schnier C, Janbek J, Lathe R, et al. Reduced dementia incidence after varicella zoster vaccination in Wales 2013–2020. Alzheimers Dement (N Y). 2022;8(1):e12293.
   PubMedGoogle Scholar
• Scherrer JF, Salas J, Wiemken TL, et al. Impact of herpes zoster vaccination on incident dementia: a retrospective study in two patient cohorts. PLoS One. 2021;16(11):e0257405.
   PubMed Web of Science ®Google Scholar
• Bae S, Yun SC, Kim MC, et al. Association of herpes zoster with dementia and effect of antiviral therapy on dementia: a population-based cohort study. Eur Arch Psychiatry Clin Neurosci. 2021;271(5):987–997.
   PubMed Web of Science ®Google Scholar
• Lophatananon A, Mekli K, Cant R, et al. Shingles, Zostavax vaccination and risk of developing dementia: a nested case-control study-results from the UK Biobank cohort. BMJ Open. 2021;11(10):e045871.
   PubMed Web of Science ®Google Scholar
• Warren-Gash C, Williamson E, Shiekh SI, et al. No evidence that herpes zoster is associated with increased risk of dementia diagnosis. Ann Clin Transl Neurol. 2022;9(3):363–374.
   PubMed Web of Science ®Google Scholar
• Johannesdottir Schmidt SA, Veres K, Sorensen HT, et al. Incident herpes zoster and risk of dementia: a population-based danish cohort study. Neurology. 2022;99(7):e660–e668.
   PubMed Web of Science ®Google Scholar
• Wu X, Yang H, He S, et al. Adult vaccination as a protective factor for dementia: a meta-analysis and systematic review of population-based observational studies. Front Immunol. 2022;13:872542
   PubMed Web of Science ®Google Scholar
• Wiemken TL, Salas J, Morley JE, et al. Comparison of rates of dementia among older adult recipients of two, one, or no vaccinations. J Am Geriatr Soc. 2022;70(4):1157–1168.
   PubMed Web of Science ®Google Scholar
• Greenwood B. The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond B Biol Sci. 2014;369:1645.
   Web of Science ®Google Scholar
• Shpilsky GF, Takahashi H, Aristarkhova A, et al. Bacillus Calmette-Guerin ‘s beneficial impact on glucose metabolism: evidence for broad based applications. iScience. 2021;24(10):103150.
   PubMed Web of Science ®Google Scholar
• Suda M, Shimizu I, Katsuumi G. al. e. Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice. Nat Aging. 2021;1:1117–1126.
   PubMedGoogle Scholar
• Mendelsohn AR, Larrick JW. Antiaging Vaccines Targeting Senescent Cells. Rejuvenation Res. 2022;25(1):39–45.
   PubMed Web of Science ®Google Scholar
• Piotto C, Julier Z, Martino MM. Immune regulation of tissue repair and regeneration via mirnas-new therapeutic target. Front Bioeng Biotechnol. 2018;6:98
   PubMed Web of Science ®Google Scholar
• Aaby P, Benn C, Nielsen J, et al. Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ Open. 2012;2(3):e000707.
   PubMed Web of Science ®Google Scholar
• Biering-Sorensen S, Aaby P, Lund N, et al. Early BCG-Denmark and neonatal mortality among infants weighing <2500 g: a randomized controlled trial. Clin Infect Dis. 2017;65(7):1183–1190.
   PubMed Web of Science ®Google Scholar
• Stensballe LG, Ravn H, Birk NM, et al. BCG vaccination at birth and rate of hospitalization for infection until 15 months of age in danish children: a randomized clinical multicenter trial. J Pediatric Infect Dis Soc. 2019;8(3):213–220.
   PubMed Web of Science ®Google Scholar
• Thostesen LM, Kjaer HF, Pihl GT, et al. Neonatal BCG has no effect on allergic sensitization and suspected food allergy until 13 months. Pediatr Allergy Immunol. 2017;28(6):588–596.
   PubMed Web of Science ®Google Scholar
• Gurfinkel EP, Leon de la Fuente R, Mendiz O, et al. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J. 2004;25(1):25–31.
   PubMed Web of Science ®Google Scholar
• Gurfinkel EP, de la Fuente RL, Mendiz O, et al. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) study. Circulation. 2002;105(18):2143–2147.
   PubMed Web of Science ®Google Scholar
• Ciszewski A, Bilinska ZT, Brydak LB, et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J. 2008;29(11):1350–1358.
   PubMed Web of Science ®Google Scholar
• Laupèze B, van der Most R, Del Giudice G. Novel technologies to improve vaccines for older adults. In: Weinberger B, editor. Vaccines for older adults: current practices and future opportunities. Basel (Karger): Interdiscip Top Gerontol Geriatr; 2020. Vol. 43. p. 218–233.
   Google Scholar
• Poolman JT. Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections. NPJ Vaccines. 2020;5:84
   PubMed Web of Science ®Google Scholar
• Doherty TM, Connolly MP, Del Giudice G, et al. Vaccination programs for older adults in an era of demographic change. Eur Geriatr Med. 2018;9(3):289–300.
   PubMed Web of Science ®Google Scholar